Publikacje

 

  1. Abusamra R, Król M, Milewski K, Kachel M, Abudaqa L, Jankowska-Sanetra J, Derbisz K, Sanetra K, Sobieszek A, Buszman PP, Wojakowski W, Buszman PE, Bochenek A, Cisowski M. Short and long-term results of endoscopic atraumatic coronary artery off-pump bypass grafting in patients with left anterior descending artery stenosis. Cardiol J. 2019 Jan 31. doi: 10.5603/CJ.a2019.0006.
  2. Buszman PE, Derbisz K, Kwasiborski P, Chrząszcz P, Mularska M, Baron D, Sobieszek A, Mendyk A, Skoczylas P, Cisowski M, Buszman PP, Milewski K.Impact of air pollution on hospital patients admitted with ST- and non-ST-segment elevation myocardial infarction in heavily polluted cities within the European Union. Cardiol J. 2018 Dec 19. doi: 10.5603/CJ.a2018.0156.
  3. Milewski K, Małecki A, Orszulik-Baron D, Kachel M, Hirnle P, Orczyk M, Dunal R, Mikołajowski G, Janas A, Nowak Z, Kozak K, Roskiewicz W, Nierwińska K, Izworski A, Rybicki A, Buszman PP, Piotrowicz R, Buszman PE.The use of modern telemedicine technologies in an innovative optimal cardiac rehabilitation program for patients after myocardial revascularization: Concept and design of RESTORE, a randomized clinical trial. Cardiol J. 2018 Dec 21. doi: 10.5603/CJ.a2018.0157.
  4. Buszman PP, Nowakowski P, Milewski K, Orlik B, Żurakowski A, Ludyga T, Polczyk F, Dębiński M, Jelonek M, Kachel M, Gąsior M, Granada JF, Kiesz RS, Buszman PE. Clinical Randomized Trial Evaluating Novel, Microcrystalline, and Biocompatible Polymer Paclitaxel-Coated Balloon for the Treatment of Femoropopliteal Occlusive Disease: The BIOPAC Trial.JACC Cardiovasc Interv. 2018 Dec 10;11(23):2436-2438. doi: 10.1016/j.jcin.2018.07.029
  5. Czerwińska-Jelonkiewicz K, Cisowski M, Bochenek A, Buszman P, Milewski K, Kunik P, Mularska M, Kocot K, Politowski P, Brączkowski J, Trznadel A, Aboodi MS, Buszman P Low molecular weight heparin in surgical valve procedures: When and how much for an optimal prophylaxis? Cardiol J. 2018 Nov 28. doi: 10.5603/CJ.a2018.0146
  6. Janas AJ, Milewski KP, Buszman PP, Trendel W, Kolarczyk-Haczyk A, Hochuł M, Pruski M Jr, Wojakowski W, Buszman PE, Kiesz RS. Long term outcomes in diabetic patients treated with atherectomy for peripheral artery disease. Cardiol J. 2018 Nov 5. doi: 10.5603/CJ.a2018.0122.
  7. Abizaid A, Kedev S, Kedhi E, Talwar S, Erglis A, Hlinomaz O, Masotti M, Fath-Ordoubadi F, Lemos PA, Milewski K, Botelho R, Costa R, Bangalore S. Randomised comparison of a biodegradable polymer ultra-thin sirolimus-eluting stent versus a durable polymer everolimus-eluting stent in patients with de novo native coronary artery lesions: the meriT-V trial. EuroIntervention. 2018 Dec 7;14(11):e1207-e1214. doi: 10.4244/EIJ-D-18-00762.
  8. Orlik B, Milewski K, Derbisz K, Jelonek M, Chrząszcz P, Beil S, Młodziankowski A, Picheta W, Buszman PP, Buszman PE. Comparison of the Absorb bioresorbable vascular scaffold to the Xience durable polymer everolimus-eluting metallic stent in routine clinical practice: a propensity score-matched analysis from a multicenter registry. Postepy Kardiol Interwencyjnej. 2018;14(2):149-156. doi: 10.5114/aic.2018.76406. Epub 2018 Jun 19.Kosmidou J,Chen S,
  9. Kappetein AP, Serruys, PW, Gersh BJ, Puskas, JD, Kandzari DE, Taggart DP, Morice MC, Buszman PE, Bochenek A, Schampaert, Page P, Sabik JF, McAndrew T, Redfors B ,Ben-Yehuda O, Stone GW. New-Onset Atrial Fibrillation After PCI or CABG for Left Main Disease The EXCEL Trial. Journal Of The American College Of Cardiology. 2018 Feb 20;71(7):739-748
  10. Janas A, Milewski K, Buszman PP,Janas K, Blachut A, Pruski M, Wiernek S, Zurakowski A, Buszman PE, Kiesz SR. Safety and feasibility of same-day early discharge after endovascular revascularization of lower extremities in elderly. SENIOR-ER registry. Catheterization and Cardiovascular Interventions. 2018 Feb15;91(3):515-520
  11. de Winter RJ, Katagiri Y, Asano T, Milewski KP, Lurz P, Buszman P, Jessurun GAJ, Koch KT, Troquay RPT, Hamer BJB, Ophuis TO, Wohrle J, Wyderka R, Cayla G, Hofma SH, Levesque S, Zurakowski  A, Fischer D, Kosmider M, Goube P, Arkenbout EK, Noutsias M, Ferrari  MW, Onuma Y, Wijns W, Serruys PW. A sirolimus-eluting bioabsorbable polymer-coated stent (MiStent) versus an everolimus-eluting durable polymer stent (Xience) after percutaneous coronary intervention (DESSOLVE III): a randomised, single-blind, multicentre, non-inferiority, phase 3 trial. Lancet. 2018 Feb 3;391(10119):431-440
  12. Prochazka V, Jurcikova J, Vitkova K, Pavliska L, Porubova  L, Lassak O, Buszman P, Fernandez CA, Jaluvka F, Spackova I, Lochman I, Prochazka M, Janikova M, Tauber Z, Frankova J, Lachnit M, Hiles MC, Johnstone BH. The Role of miR-126 in Critical Limb Ischemia Treatment Using Adipose-Derived Stem Cell Therapeutic Factor Concentrate and Extracellular Matrix Microparticles. Medial Science Monitor.2018 Jan 26;24:511-522
  13. Suna G, Wojakowski W, Lynch M, Barallobre-Barreiro J, Yin XK, Mayr U, Baig F, Lu  RF, Fava M, Hayward R, Molenaar C, White SJ, Roleder T,  Milewski KP, Gasior P, Buszman PP, Buszman P, Jahangiri M, Shanahan CM, Hill J, Mayr M. Extracellular Matrix Proteomics Reveals Interplay of Aggrecan and Aggrecanases in Vascular Remodeling of Stented Coronary Arteries. Circulation. 2018 Jan 9;137(2):166-183
  14. Kachel M, Milewski K, Buszman P, Michalak M, Domaradzki W, Gerber  W, Sliwka J, Nozynski J, Sobota M, Hirnle P, Bialek-Brodocz M, Zembala M, Pawlak M, Plowiecki E, Kasperczyk J, Mezyk, A, Bochenek A, Buszman P. State-of-the-art of transcatheter treatment of aortic valve stenosis and the overview of the InFlow project aiming at developing the first Polish TAVI system. Cardiology journal. 2017 Dec;24(6): 685-694
  15. Escaned J,Collet C, Ryan N, De Maria GL, Walsh S, Sabate M, Davies J, Lesiak M, Moreno R, Cruz-Gonzalez I, Hoole SP, West NE, Piek JJ, Zaman A, Fath-Ordoubadi F, Stables RH, Appleby C, van Mieghem N, van Geuns RJ, Uren N, Zueco J, Buszman P, Iniguez A, Goicolea J, Hildick-Smith D, Ochala A, Dudek D, Hanratty C, Cavalcante R, Kappetein AP, Taggart DP, van Es GA, Morel MA, de Vries T, Onuma Y, Farooq V, Serruys PW, Banning AP. Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study. European heart journal. 2017 Nov 7;38(42):3124-3134
  16. Bil J, Gil RJ, Pawlowski T, Milewski KP. Assessment of vascular response to BiOSS LIM C-(R) stents vs Orsiro((R)) stents in the porcine coronary artery model. Cardiovascular Therapeutics. 2017 Aug;35(4)
  17. Tajstra M, Sokal A, Gwozdz A, Wilczek M, Gacek A, Wojciechowski K, Gadula-Gacek E, Adamowicz-Czoch E, Chlosta-Niepieklo K, Milewski K, Rozentryt P, Kalarus Z, Gasior M, Polonski L. REmote SUpervision to Decrease HospitaLization RaTe. Unified and integrated platform for data collected from devices manufactured by different companies: Design and rationale of the RESULT study. Annals Of Noninvasive Electrocardiology. 2017 Jul;22(4)
  18. Kedhi E, Fabris E, van der Ent M, Kennedy MW, Buszman P, von Birgelen C, Cook S, Wedel H, Zijlstra F. A prospective, randomized, open-label trial of 6-month versus 12-month dual antiplatelet therapy after drug-eluting stent implantation in ST-elevation myocardial infarction: Rationale and design of the "DAPT-STEMI trial". American Heart Journal. 2017 Jun;188:11-17
  19. Gil RJ, Bil J, Kaczynski M, Milewski KP.  BiOSS LIM C: thin-strut cobalt-chromium version of the dedicated bifurcation stent. Expert Reviev Of Medical Devices. 2017 Apr;14(4):279-284
  20. Janas A, Buszman PP, Milewski KP, Wiernek S, Janas K, Pruski M, Wojakowski W, Blachut A, Picheta W, Buszman P, Kiesz S. Long-Term Outcomes After Percutaneous Lower Extremity Arterial Interventions With Atherectomy vs. Balloon Angioplasty -Propensity Score-Matched Registry-.Circulation Journal. 2017 Mar;81(3):376-382
  21. Pruski MJ, Blachut AM, Konkolewska M, Janas A, Hrycek E, Buszman PP, Kiesz, RS. MynxGrip for Closure of Antegrade Puncture After Peripheral Interventions With Same-Day Discharge. Vascular and Endovascular Surgery. 2017 Feb;51(2):67-71
  22. Reczuch K, Milewski K, Wasek W, Rzeszutko L, Wojakowski W, Hawranek M, Wlodarczak A, Pawlowski T, Kochman J, Dobrzycki S, Grygier M, Ochala A, Wojcik J, Lesiak M, Dudek D, Legutko, J. Bioresorbable scaffolds in the treatment of coronary artery disease. Expert consensus statement of the Association of Cardiovascular Interventions of the Polish Cardiac Society (ACVI PCS). Kardologia Polska.2017;75(8):817-835.
  23. Milewski K, Fiszer R, Buszman PP, Weglarz P, Janas A, Krauze A, Jelonek M, Hirnle P, Smolka G, Gil R,  Bialkowski J, Buszman PE. Temporal healing patterns and coverage dynamics after new Polish transcatheter PFO occluder implantation in a swine. Kardiologia Polska.2017;75(9):907-913.
  24. Debinski M, Kondys M, Buszman PE. Risk assessment in patients with ST elevation myocardial infarction treated with primary percutaneous coronary angioplasty. Does reduced duration of hospital stay affect the prognosis? Kardiologia Polska.2017;75(7):635-640
  25. Stone GW, Sabik JF, Serruys PW, Simonton CA, Genereux P, Puskas J, Kandzari DE, Morice MC, Lembo N, Brown WM, Taggart DP, Banning A, Merkely B, Horkay F, Boonstra PW, van Boven AJ, Ungi I, Bogats G, Mansour S, Noiseux N, Sabate M, Pomar J, Hickey M, Gershlick A, Buszman P, Bochenek A, Schampaert E, Page P, Dressler O, Kosmidou I, Mehran R, Pocock SJ, Kappetein AP. Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease. New England Journal Of Medicine.2016 Dec 8;375(23):2223-2235.
  26.  Zurakowski A, Konkolewska M, Nowakowski P, Buszman, P. New treatment possibilities for patients with advanced coronary artery disease and critical limb ischemia - a feasibility study. Postepy w Kardiologiii Interwencyjnej. 2016 Dec;12(4):368-371
  27. Capodanno D, Gargiulo G, Buccheri S, Chieffo A, Meliga E, Latib A, Park SJ, Onuma Y, Capranzano P, Valgimigli M, Narbute I, Makkar RR, Palacios IF, Kim YH, Buszman PE, Chakravarty T, Sheiban I, Mehran R, Naber C, Margey R, Agnihotri A, Marra S, Leon MB, Moses JW, Fajadet J, Lefevre T, Morice MC, Erglis A, Alfieri O, Serruys PW, Colombo A, Tamburino C. Computing Methods for Composite Clinical Endpoints in Unprotected Left Main Coronary Artery Revascularization A Post Hoc Analysis of the DELTA Registry. Jacc-Cardiovascular Interventions. 2016 Nov 28;9(22):2280-228
  28. Milewski K. Gasior P, Samborski S, Buszman PP, Blachut A, Wojtaszczyk A, Mlodziankowski A, Mendyk A, Krol M, Wojakowski W, Buszman, PE. Evaluation of safety and efficacy of NexGen - an ultrathin strut and hybrid cell design cobalt-chromium bare metal stent implanted in a real life patient population - the Polish NexGen Registry. POSTEPY W KARDIOLOGII INTERWENCYJNEJ. 2016 Sep: 12(3):217-223
  29. Pyxaras SA, Hunziker L ,Chieffo A, Meliga E, Latib A, Park SJ, Onuma Y, Capranzano P, Valgimigli M, Narbute I, Makkar RR, Palacios IF, Kim YH, Buszman PP, Chakravarty T, Sheiban I, Mehran R, Margey R, Agnihotri A, Marra S, Capodanno D, Leon MB, Moses JW, Fajadet J, Lefevre T, Morice MC, Erglis A, Tamburino C, Alfieri O, Serruys PW, Colombo A, Naber CK. Long-term clinical outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for acute coronary syndrome from the DELTA registry: a multicentre registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment. EUROINTERVENTION. 2016 Aug;12(5):E623-E631.
  30. Charytan DM, Desai M, Mathur M, Stern NM, Brooks MM, Krzych LJ, Schuler GC, Kaehler J, Rodriguez-Granillo AM, Alfredo M, Hueb W, Reeves BC, Thiele H, Rodriguez AE, Buszman PP, Buszman PE, Maurer R, Winkelmayer WC. Reduced risk of myocardial infarct and revascularization following coronary artery bypass grafting compared with percutaneous coronary intervention in patients with chronic kidney disease. Kidney International.2016 Aug;90(2):411-421.
  31. Nickenig G, Schueler R, Dager A, Clark PM, Abizaid A, Siminiak T, Buszman P, Demkow M, Ebner A, Asch FM, Hammerstingl C. Treatment of Chronic Functional Mitral Valve Regurgitation With a Percutaneous Annuloplasty System. : Journal of the american college of cardiology. 2016 Jun 28;67(25):2927-2936
  32. Grundeken MJ, Wykrzykowska JJ, Ishibashi Y, Garg S, de Vries T, Garcia-Garcia HM, Onuma Y, de Winter RJ, Buszman P, Linke A, Ischinger T, Klauss V, Eberli F, Corti R, Wijns W, Morice MC, di Mario C, Meier B, Juni P, Yazdani A, Copt S, Windecker S, Serruys PW. First Generation Versus Second Generation Drug-Eluting Stents for the Treatment of Bifurcations: 5-Year Follow-Up of the LEADERS All-Comers Randomized Trial. : CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS. 2016 Jun;87(7):E248-E260 
  33. Buszman PE, Buszman PP, Banasiewicz-Szkrobka I, Milewski KP, Zurakowski A, Orlik B, Konkolewska M, Trela B, Janas A, Martin JL, Kiesz RS, Bochenek A. Left Main Stenting in Comparison With Surgical Revascularization 10-Year Outcomes of the (Left Main Coronary Artery Stenting) LE MANS Trial. JACC-CARDIOVASCULAR INTERVENTIONS. 2016 Feb 22;9(4):318-327
  34. Wilczynski M, Wybraniec MT, Milewski K, Sanak M, Wita K, Buldak L, Kondys M, Buszman P, Bochenek A. Eptifibatide infusion versus placebo in high risk patients with non-ST segment elevation acute coronary syndromes managed with urgent coronary artery bypass graft surgery. A prospective multicenter randomized placebo-controlled clinical trial. JOURNAL OF CARDIOVASCULAR SURGERY. 2016 Feb;57(1):100-110
  35. Weisz G, Genereux P, Iniguez A,  Zurakowski A, Shechter M, Alexander KP, Dressler O, Osmukhina A, James S, Ohman EM, Ben-Yehuda O, Farzaneh-Far R, Stone GW. Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): a multicentre, randomised, double-blind, placebo-controlled trial. LANCET. 2016 Jan 9;387(10014):136-145 
  36. Ghione M, Wykrzykowska JJ, Windecker S, Serruys PW, Buszman P, Linke A, Sohn HY, Corti R, Antoni D, Wijns W, Estevez-Loureiro R, Morice MC, Van Es GA, van Geuns RJ, Juni P, Eerdmans P, De Vries T, Konik S, Di Mario C. Five-year outcomes of chronic total occlusion treatment with a biolimus A9-eluting biodegradable polymer stent versus a sirolimus-eluting permanent polymer stent in the LEADERS all-comers trial. CARDIOLOGY JOURNAL. 2016;23(6):626-636 
  37. Buszman PP,  Michalak M, Pruski M, Fernandez C, Jelonek M, Janas A, Savard C, Gwiazdowska-Nowotka B, Zurakowski A, Wojakowski W, Buszman PE, Milewski K. Comparable vascular response of a new generation sirolimus eluting stents when compared to fluoropolymer everolimus eluting stents in the porcine coronary restenosis model. Cardiology Journal. 2016;23(6):657-666
  38. Gasior M, Pres D, Wojakowski W, Buszman P, Kalarus Z, Hawranek M, Gierlotka M, Lekston A, Mizia-Stec K, Zembala M, Polonski L, Tendera M. Causes of hospitalization and prognosis in patients with cardiovascular diseases. POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE.2016;126(10):754-762 
  39.  Kadziela J, Prejbisz A, Kostka-Jeziorny K, Dudek D, Narkiewicz K, Sadowski J, Lekston A, Gziut A, Wiecek A, Buszman P, Kleinrok A, Kochman J, Czarnecka D, Januszewicz A, Witkowski A. Effects of renal sympathetic denervation on blood pressure and glycaemic control in patients with true resistant hypertension: results of Polish Renal Denervation Registry (RDN-POL Registry). Kardiologia Polska.2016;74(9):961-968
  40. Prochazka V, Jurcikova J, Lassak O, Vitkova K, Pavliska L, Porubova L, Buszman PP, Krauze A, Fernandez C, Jaluvka F, Spackova I, Lochman I, Dvorackova J, Merfeld-Clauss S, March KL, Traktuev DO, Johnstone BH. Therapeutic Potential of Adipose-Derived Therapeutic Factor Concentrate for Treating Critical Limb Ischemia. CELL TRANSPLANTATION.2016;25(9):1623-1633
  41. Szymanski RJ, Kiesz RS, Wiernek SL, Wiernek B, Kawecki D, Debinski M, Kondys M, Olszewski R, Szygula J, Buszman PE. Utilisation of bivalirudin and vascular closure devices for same-day discharge after percutaneous coronary and peripheral interventions. KARDIOLOGIA POLSKA.2016;74(6):553-560 
  42. Milewski K, Fil W, Buszman P, Janik M, Wanha W, Martin T, Krol M, Gorycki B, Wiernek S, Krzych L, Kiesz RS, Wojakowski W, Buszman P. Renal Artery Stenting Associated With Improvement in Renal Function and Blood Pressure Control in Long-Term Follow-Up. KIDNEY & BLOOD PRESSURE RESEARCH.2016;41(3):278-287
  43.  Orlik B, Buszman PP, Krauze A, Gasior P, Desperak P, Pajak J, Kasperczyk J, Janas A, Jelonek M, Handzlik-Orlik G, Buszman PE, Milewski K. A Nuclear Magnetic Resonance Spectroscopy as a Method for Evaluation of In Vivo Poly-l-Lactide Biodegradation Kinetics From Stent-Polymer Matrices: An Experimental Study Utilizing Porcine Model of In-Stent Restenosis. OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS.2016 Jan;21(1):93-99 
  44. Zurakowski A, Buszman PP, Milewski KP, Janas A, Gorycki B, Kondys M, Gasior P, Michalak M, Boxberger M, Peppas A, Granada JF, Buszman PE. Stenting and Adjunctive Delivery of Paclitaxel Via Balloon Coating Versus Durable Polymeric Matrix for De Novo Coronary Lesions: Clinical and Angiographic Results from the Prospective Randomized Trial. JOURNAL OF INTERVENTIONAL CARDIOLOGY.2015 Aug;28(4):348-357
  45. Wiernek SL, Kiesz RS, Wiernek BK, Buszman PP, Janas A, Martin JL, Trela B, Szewc RG, Buszman PE. Treatment of symptomatic coronary artery disease in patients with end-stage renal disease on hemodialysis with paclitaxel-eluting TAXUS stent. HEMODIALYSIS INTERNATIONAL.2015 Jul;19(3):402-411
  46. Handzlik-Orlik G, Holecki M, Orlik B, Wylezol M, Dulawa J. Nutrition Management of the Post-Bariatric Surgery Patient. NUTRITION IN CLINICAL PRACTICE.2015 Jun;30(3):383-392
  47.   Zalewski J, Claus P, Bogaert J, Vanden Driessche N, Driesen RB, Galan DT, Sipido KR, Buszman P, Milewski K, Van de Werf F. Cyclosporine A reduces microvascular obstruction and preserves left ventricular function deterioration following myocardial ischemia and reperfusion. BASIC RESEARCH IN CARDIOLOGY.2015 Mar;110(2),  Article Number: 18 .
  48. Stepien E, Konkolewska M, Kapusta M, Zurakowski A. Correlation between the number and origin of circulating microparticles and fibrin clot properties in patients with coronary artery disease (Retraction of vol 181C, pg 147, 2014). INTERNATIONAL JOURNAL OF CARDIOLOGY.2015 Feb 15;181: R1-R1
  49. Zhang YJ, Iqbal J, Windecker S, Linke A, Antoni D, Sohn HY, Corti R, van Es GA, Copt S, Eerdmans P, Saitta R, Morice MC, Di Mario C, Juni P, Wijns W, Buszman P, Serruys PW. Biolimus-eluting stent with biodegradable polymer improves clinical outcomes in patients with acute myocardial infarction. HEART.2015 Feb 15;10(4):271-278 
  50. Ulczok R, Milewski K, Bis J, Samborski S, Krauze A, Jelonek M, Guc M, Smyczek D, Aboodi M, Maciejewski A, Buszman PE, Bochenek A, Wojakowski W, Krejca M. A novel peritoneum derived vascular prosthesis formed on a latex catheter in an SDF-1 chemokine enriched environment: a pilot study. INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS.2015 Feb;38(2):89-95. DOI: 10.5301/ijao.5000396 
  51. Buszman PP, Orlik B, Pajak J, Jelonek M, Krauze A, Janas A, Legutko J,Wojakowski W, Buszman PE, Milewski K. Dose-dependent vascular response following delivery of sirolimus via fast releasing, biodegradable polymer stent matrix: an experimental study in the porcine coronary model of restenosis. : KARDIOLOGIA POLSKA.2015;73(10): 916-923  DOI: 10.5603/KP.a2015.0085 
  52.  Janas A, Milewski K, Buszman PP, Nowakowski P, Jelonek M, Orlik B, Krauze A, Samborski S, Beaudry D, Lecelrc G, Krol M, Lapointe JM, Wojakowski W, Turek A, Kiesz RS, Buszman PE. Safety and biocompatibility of a novel self-expanding nitinol carotid stent with hybrid cell design in a porcine model of neointimal hyperplasia. KARDIOLOGIA POLSKA.2015;73(4): 240-245  DOI: 10.5603/KP.a2014.0219
  53. Buszman PP, Milewski K, Pajak J, Jelonek M, Orlik B, Krauze A, Gwiazdowska-Nowotka B, Wojakowski W, Tellez A, Granada JF, Buszman PE. Differences in vessel healing following delivery of everolimus or paclitaxel: a comparative experimental study using identical stent and biodegradable polymer platforms. EUROINTERVENTION.2014 Oct;10(6): 724-731  DOI: 10.4244/EIJV1016A125 
  54. Buszman PE, Buszman PP, Bochenek A, Gierlotka M, Gasior M, Milewski K, Orlik B, Janas A, Wojakowski  W, Kiesz RS, Zembala M, Polonski L. Comparison of Stenting and Surgical Revascularization Strategy in Non-ST Elevation Acute Coronary Syndromes and Complex Coronary Artery Disease (from the Milestone Registry). AMERICAN JOURNAL OF CARDIOLOGY.2014 Oct 1;114(7): 979-987  DOI: 10.1016/j.amjcard.2014.07.008 
  55. Conrotto F, Scacciatella P, D'Ascenzo F, Chieffo A, Latib A, Park SJ, Kim YH, Onuma Y, Capranzano P, Jegere S, Makkar R, Palacios I, Buszman P,Chakravarty T, Mehran R,  Naber C, Margey R, Leon M, Moses J, Fajadet J, Lefevre T, Morice MC, Erglis A, Tamburino C, Alfieri O, D'Amico M, Marra S, Serruys PW, Colombo A, Meliga E. Long-Term Outcomes of Percutaneous Coronary Interventions or Coronary Artery Bypass Grafting for Left Main Coronary Artery Disease in Octogenarians (from a Drug-Eluting stent for LefT main Artery Registry Substudy). :AMERICAN JOURNAL OF CARDIOLOGY.2014 Jun 15;133(12): 2007-2012  DOI: 10.1016/j.amjcard.2014.03.044
  56. Buchanan GL, Chieffo A, Meliga E, Mehran R, Park SJ, Onuma Y, Capranzano P, Valgimigli M, Narbute I, Makkar RR, Palacios IF, Kim YH, Buszman PP, Chakravarty T, Sheiban I, Naber C, Margey R, Agnihotri A, Marra S, Capodanno D, Allgar V, Leo MB, Moses JW, Fajadet J, Lefevre T, Morice MC, Erglis A, Tamburino C, Alfieri O, Serruys PW, Colombo A. Comparison of Percutaneous Coronary Intervention (With Drug-Eluting Stents) Versus Coronary Artery Bypass Grafting in Women With Severe Narrowing of the Left Main Coronary Artery (from the Women-Drug-Eluting stent for LefT main coronary Artery disease Registry). AMERICAN JOURNAL OF CARDIOLOGY.2014 Apr 15;113(8): 1348-1355  DOI: 10.1016/j.amjcard.2014.01.409
  57. Naganuma T, Chieffo A, Meliga E, Capodanno D, Park SJ, Onuma Y, Valgimigli M, Jegere S, Makkar RR, Palacios IF, Costopoulos C, Kim YH, Buszman PP, Chakravarty T, Sheiban I, Mehran R, Naber C, Margey R, Agnihotri A, Marra S, Capranzano P, Leon MB, Moses JW, Fajadet J, Lefevre T, Morice MC, Erglis A, Tamburino C, Alfieri O, Serruys PW, Colombo A. Long-Term Clinical Outcomes After Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting for Ostial/Midshaft Lesions in Unprotected Left Main Coronary Artery From the DELTA Registry. JACC-CARDIOVASCULAR INTERVENTIONS.2014 Apr;7(4): 354-361  DOI: 10.1016/j.jcin.2013.11.014 
  58. Buszman PP, Milewski K, Zurakowski A, Pajak J, Jelonek M, Gasior P, Peppas A, Tellez A, Granada JF, Buszman PE. Experimental Evaluation of Pharmacokinetic Profile and Biological Effect of a Novel Paclitaxel Microcrystalline Balloon Coating in the Iliofemoral Territory of Swine. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS. 2014 Feb 1;83(2): 325-333  DOI: 10.1002/ccd.24982 
  59. Naganuma T, Chieffo A, Meliga E, Capodanno D, Park SJ, Onuma Y, Valgimigli M, Jegere S, Makkar RR, Palacios IF, Costopoulos C, Kim YH, Buszman PP, Chakravarty T, Sheiban I, Mehran R, Naber C, Margey R, Agnihotri A, Marra S, Capranzano P, Leon MB, Moses JW, Fajadet J, Lefevre T, Morice MC, Erglis A, Tamburino C, Alfieri O, Serruys PW, Colombo A. Long-Term Clinical Outcomes After Percutaneous Coronary Intervention for Ostial/Mid-Shaft Lesions Versus Distal Bifurcation Lesions in Unprotected Left Main Coronary Artery The DELTA Registry (Drug-Eluting Stent for Left Main Coronary Artery Disease): A Multicenter Registry Evaluating Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting for Left Main Treatment. JACC-CARDIOVASCULAR INTERVENTIONS.2013 Dec;6(12): 1242-1249  DOI: 10.1016/j.jcin.2013.08.005   
  60. Meliga E, De Benedictis M, Chieffo A, Latib A, Park SJ, Kim YH, Onuma Y, Capranzano P, Jegere S, Makkar R, Palacios I, Buszman P, Bande M, Chakravarty T, Mehran R, Naber C, Scroccai I, Margey R, Leon M, Moses J, Fajadet J, Lefevre T, Morice MC, Erglis A, Colombo A, Alfieri O, Conte MR, Serruys PW, Colombo A. Coronary artery bypass graft versus percutaneous coronary intervention with drug-eluting stent implantation for diabetic patients with unprotected left main coronary artery disease: the D-DELTA registry. EUROINTERVENTION. 2013 Nov;9(7): 803-808  DOI: 10.4244/EIJV9I7A133
  61. Buszman PP, Orlik B, Trela B, Milewski K, Kozlowski M, Pruski M, Drzewiecki J, Peppas A, Granada JF, Kaluza GL Buszman. Comparable clinical safety and efficacy of biodegradable versus durable polymer paclitaxel eluting stents despite shorter dual antiplatelet therapy: Insights from a multicenter, propensity score-matched registry. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS.2013 Sep 1;82(3): E155-E162  DOI: 10.1002/ccd.24732
  62. Kiesz RS, Wiernek SL, Wiernek BK, Radvany MG, Buszman PP, Szymanski R, Konkolewska MD, Martin JL, Buszman PE. Long-term results of plaque excision combined with aggressive pharmacotherapy in high-Risk patients with advanced peripheral artery disease (SAVE a LEG registry). CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS.2013 Sep 1;82(3): E244-E250  DOI: 10.1002/ccd.24756
  63. Buszman PP, Tellez A, Afari M, Cheng YP, Conditt GB, McGregor JC, Milewski K, Stenoien M, Kaluza GL, Granada JF. Stent healing response following delivery of paclitaxel via durable polymeric matrix versus iopromide-based balloon coating in the familial hypercholesterolaemic swine model of coronary injury. EUROINTERVENTION.2013 Aug;9(4): 510-516 
  64. Serruys PW, Farooq V, Kalesan B, de Vries T, Buszman P, Linke A, Ischinger T, Klauss V, Eberli F, Wijns W, Morice MC, Di Mario C, Corti R, Antoni D, Sohn HY, Eerdmans P, Rademaker-Havinga T, van Es GA, Meier B, Juni P, Windecker S. Improved Safety and Reduction in Stent Thrombosis Associated With Biodegradable Polymer-Based Biolimus-Eluting Stents Versus Durable Polymer-Based Sirolimus-Eluting Stents in Patients With Coronary Artery Disease Final 5-Year Report of the LEADERS (Limus Eluted From A Durable Versus ERodable Stent Coating) Randomized, Noninferiority Trial. JACC-CARDIOVASCULAR INTERVENTIONS.2013 Aug;6(8): 777-789  DOI: 10.1016/j.jcin.2013.04.011
  65. Wojakowski W, Pyrlik A, Krol M, Buszman P, Ochala A, Milewski K, Smolka G, Kawecki D, Rudnik A, Pawlowski T, Jadczyk T, Wyderka R, Cybulski W, Dworowy S,Tendera M. Circulating endothelial progenitor cells are inversely correlated with in-stent restenosis in patients with non-ST-segment elevation acute coronary syndromes treated with EPC-capture stents (JACK-EPC trial). MINERVA CARDIOANGIOLOGICA. 2013 Jun;61(3): 301-311
  66. Czerwinski W, Debinski M, Szpak-Ulczok S, Szafert-Gesikowska E, Wrebiak-Trznadel M, Kondys M, Jarzab B, Buszman P. Heart failure due to chronic hypoparathyroidism in patient with acute coronary syndrome. KARDIOLOGIA POLSKA.2013;71(6): 606-608  DOI: 10.5603/KP.2013.0125 
  67. Zurek P, Debinski M, Czerwinski W, Kondys M, Buszman P. Acute myocardial infarction with simultaneous occlusions of two coronary arteries in a 44 year-old man. KARDIOLOGIA POLSKA. 2013;71(3): 279-282  DOI: 10.5603/KP.2013.0042   
  68. Granada JF,  Buszman PP. Renal Denervation Therapies for Refractory Hypertension. CURRENT CARDIOLOGY REPORTS.2012 Oct;14(5): 619-625  DOI: 10.1007/s11886-012-0303-9 
  69. Wojakowski W, Tendera M, Cybulski W, Zuba-Surma EK, Szade K, Florczyk U, Kozakowska M, Szymula A, Krzych L, Paslawska U, Paslawski R, Milewski K, Buszman PP, Nabialek E, Kuczmik W, Janiszewski A, Dziegiel P, Buszman PE, Jozkowicz A, Dulak J. Effects of intracoronary delivery of allogenic bone marrow-derived stem cells expressing heme oxygenase-1 on myocardial reperfusion injury. THROMBOSIS AND HAEMOSTASIS.2012 Sep;108(3): 464-475  DOI: 10.1160/TH12-05-0303 
  70. Buszman PP, Wojakowski W, Milewski K, Debinski M, Pajak J, Aboodi MS, Jackiewicz,W, Kawka M, Bochenek A, Prats J, Granada JF, Kaluza GL, Buszman PE. Controlled Reperfusion with Intravenous Bivalirudin and Intracoronary Abciximab Combination Therapy in the Porcine Myocardial Infarction Model. THROMBOSIS RESEARCH.2012 Aug;130(2): 265-272  DOI: 10.1016/j.thromres.2011.10.020 
  71. Milewski K, Gorycki B, Buszman PP, Jelonek M,  Beaudry D, Lapointe JM, Guy LG, Abusamra M, Pajak J, Kinasz W, Wojakowski W, Leclerc G, Gil RJ, Buszman PE. Vascular response and mechanical integrity of the new biodegradable polymer coated sirolimus-eluting PROLIM stent implanted in porcine coronary arteries. KARDIOLOGIA POLSKA.2012 Jul;70(7): 703-711
  72. Chieffo A, Meliga E, Latib A, Park SJ, Onuma Y, Capranzano P, Valgimigli M, Jegere S, Makkar RR, Palacios IF, Kim YH, Buszman PE, Chakravarty T, Sheiban I, Mehran R, Naber C, Margey R, Agnihotri A, Marra S, Capodanno D, Leon MB, Moses JW, Fajadet J, Lefevre T, Morice MC, Erglis A, Tamburino C, Alfieri O, Serruys PW, Colombo A. Drug-Eluting Stent for Left Main Coronary Artery Disease The DELTA Registry: A Multicenter Registry Evaluating Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting for Left Main Treatment. JACC-CARDIOVASCULAR INTERVENTIONS.2012 Jul;5(7): 718-727  DOI: 10.1016/j.jcin.2012.03.022
  73. Buszman PP, Szymanski R, Debinski M, Milewski K, Krol M, Nowakowski P, Kiesz RS, Radvany MG, Wiernek S, Wiernek B, Buszman PE. Long-term results of cephalad arteries percutanoeus transluminal angioplasty with stent implantation (The CAPTAS registry). CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS.2012 Mar 1;79(4): 532-540  DOI: 10.1002/ccd.23391 
  74. Wyderka R,  Wojakowski W, Jadczyk T, Maslankiewicz K, Parma Z, Pawlowski T, Musialek P, Majka M, Krol M, Kuczmik W, Dworowy S, Korzeniowska B, Ratajczak MZ, Tendera M. Mobilization of CD34+CXCR4+Stem/Progenitor Cells and the Parameters of Left Ventricular Function and Remodeling in 1-Year Follow-up of Patients with Acute Myocardial Infarction. : MEDIATORS OF INFLAMMATION.  Article Number: 564027  DOI: 10.1155/2012/564027 Published: 2012 
  75. Gil RJ,  Zasada W, Dziewierz A, Partyka L, Zarebinski M, Wilczek K, Dudek D, Buszman P, Lesiak M, Ruzyllo W. Taxcor for the prevention of restenosis. Polish multicentre observational study to assess the efficacy and safety of the Genius TAXCOR I stent. POSTEPY W KARDIOLOGII INTERWENCYJNEJ.2011 Dec;7(4): 285-291  DOI: 10.5114/pwki.2011.25786 
  76. Vassilev D, Gil R, Milewski K. Bifurcation Optimisation Stent System (BiOSS Lim) with sirolimus elution: results from porcine coronary artery model. EUROINTERVENTION.2011 Sep;7(5): 614-620 
  77. Debinski M, Buszman PP, Milewski K, Wojakowski W, Jackiewicz W, Pajak J, Szurlej D, Fryc-Stanek J, Wiernek S, Jelonek M, Spurlock ME, Martin J, Bochenek A, Buszman PE. Intracoronary adiponectin at reperfusion reduces infarct size in a porcine myocardial infarction model. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE.2011 Jun;27(6): 775-781  DOI: 10.3892/ijmm.2011.643
  78. Krol M, Skwarna B, Galuszka G, Szymanski R, Buszman P. Giant aneurysm in medial anterior descending artery: treatment with two endovascular stent grafts on bare metal stent scaffold. POSTEPY W KARDIOLOGII INTERWENCYJNEJ. 2011 Jun;7(2): 173-177  DOI: 10.5114/pwki.2011.23170 
  79. Szymanski R, Wiernek S, Wiernek B, Konkolewska M, Buszman PE, Kiesz RS. Successful recanalization of total chronic occlusion of the superficial femoral artery by antegrade subintimal angioplasty with stenting using the Pioneer Plus Re-Entry Catheter. POSTEPY W KARDIOLOGII INTERWENCYJNEJ.2011 Mar;7(1): 91-94  DOI: 10.5114/pwki.2011.21196 
  80. Kiesz RS, Wiernek BK, Wiernek SL, Merritt C, Ybarra T, Iwanski A, Buszman PP, Szymanski R, Martin JL, Buszman PE. Cardiva Catalyst II Vascular Access Management Device in Percutaneous Diagnostic and Interventional Procedures With Same-Day Discharge (CATALYST II Trial). : JOURNAL OF ENDOVASCULAR THERAPY.2011 Feb;18(1): 46-53  DOI: 10.1583/10-3237.1 
  81. Polonski L, Gasior M, Gierlotka M, Buszman P, Ruzyllo W, Dubiel J, Banasiak W, Kalarus Z, Zembala M, Opolski G. Temporal trends in treatment and outcomes of patients with non-ST-segment elevation myocardial infarction (NSTEMI) in clinical practice - analysis from the PL-ACS registry. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE  Volume: 183  Pages: 658-658  Published: 2011 
  82. Buszman P, Milewski K, Zurakowski A, Pajak J, Liszka L, Buszman P, Musiol E, AbuSamra M, Trznadel S, Kaluza G. Novel biodegradable polymer-coated, paclitaxel-eluting stent inhibits neointimal formation in porcine coronary arteries. KARDIOLOGIA POLSKA.2010 May;68(5): 503-511 
  83. Buszman PP, Bochenek A, Konkolewska M, Trela B, Kiesz RS, Wilczynski M, Cisowski M, Krejca M, Banasiewicz-Szkrobka I, Krol M, Kondys M, Wiernek S, Orlik B, Martin JL, Tendera M, Buszman PE. Early and Long-Term Outcomes after Surgical and Percutaneous Myocardial Revascularization in Patients with Non-ST-Elevation Acute Coronary Syndromes and Unprotected Left Main Disease. JOURNAL OF INVASIVE CARDIOLOGY.2009 Nov; 21(11): 564-569 
  84. Buszman PE, Buszman PP, Kiesz RS,  Bochenek A, Trela B, Konkolewska M, Wallace-Bradley D, Wilczynski M, Banasiewicz-Szkrobka I, Peszek-Przybyla E, Krol M, Kondys M, Milewski K, Wiernek S, Debinski M, Zurakowski A, Martin JL, Tendera M. Early and Long-Term Results of Unprotected Left Main Coronary Artery Stenting The LE MANS (Left Main Coronary Artery Stenting) Registry. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY.2009 Oct 13;54(16): 1500-1511  DOI: 10.1016/j.jacc.2009.07.007
  85. Spargias K, Milewski K, Debinski M, Buszman PP, Cokkinos DV, Pogge R, Buszman P. Drug Delivery at the Aortic Valve Tissues of Healthy Domestic Pigs with a Paclitaxel-Eluting Valvuloplasty Balloon. JOURNAL OF INTERVENTIONAL CARDIOLOGY.2009 Jun;22(3): 291-298  DOI: 10.1111/j.1540-8183.2009.00447.x 
  86. Wojakowski W, Tendera M, Kucia M, Zuba-Surma E, Paczkowska E, Ciosek J, Halasa M, Krol M, Kazmierski M, Buszman P, Ochala A, Ratajczak J, Machalinski B, Ratajczak MZ. Mobilization of Bone Marrow-Derived Oct-4(+) SSEA-4(+) Very Small Embryonic-Like Stem Cells in Patients With Acute Myocardial Infarction. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2009 Jan 6;53(1): 1-9  DOI: 10.1016/j.jacc.2008.09.029 
  87. Buszman PE, Buszman PP, Trela B, Konkolewska M,Krol M, Kondys M, Zurakowski A, Szkrobka I, Tendera M, Kiesz S. Early and Late Results of Left Main Stenting: LEMANS Registry. AMERICAN JOURNAL OF CARDIOLOGY. 2008 Oct 12; 102(8A): 21I-22I 
  88. Buszman PE, Buszman PP, Trela B, Konkolewska M, Krol M, Kondys M, Zurakowski A, Szkrobka I, Kiesz S, Martin JL, Tendera M. Acute and Late Results of Unprotected Left Main Stenting in Comparison With Surgical Revascularization in Patients with Non ST Elevation Acute Coronary Syndromes. AMERICAN JOURNAL OF CARDIOLOGY. 2008 Oct 12;102(8A): 91I-91I 
  89. Buszman P, Debinski M, Gruszka A, Janas P, Krol M, Kondys M, Iwinski J, Kazibutowska-Zaranska Z, Cierpka L, Tendera M. Early and late outcomes of percutaneous transluminal angioplasty of cephalad arteries. KARDIOLOGIA POLSKA. 2008 Mar; 66(3): 233-242 
  90. Buszman PE,  Kiesz SR, Bochenek A, Peszek-Przybyla E,Szkrobka I, Debinski M, Bialkowska B, Dudek D, Gruszka A, Zurakowski A, Milewski K, Wilczynski M, Rzeszutko L, Buszman P, Szymszal J, Martin JL, Tendera M. Acute and late outcomes of unprotected left main stenting in comparison with surgical revascularization. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. Volume: 51  Issue: 5  Special Issue: 519  Pages: 538-545  DOI: 10.1016/j.jacc.2007.09.054  Published: FEB 5 2008
  91. Buszman P, Trznadel S, Milewski K, Rzezniczak J, Przewlocki T, Kosmider M, Wojcik J, Janczak J, Zurakowski A, Kondys M, Krol M, Kinasz L, Jaklik A, Rzeszutko L, Kaluza GL, Kiesz S, Gil R. Novel paclitaxel-eluting, biodegradable polyrmer coated stent in the treatment of de novo coronary lesions: A prospective multicenter registry. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS.2008 Jan 1;71(1): 51-57  DOI: 10.1002/ccd.21392
  92. Buszman P,  Orlik B, Kachel M, Kolarczyk-Haczyk A, Konarski L, Czerwinska-Jelonkiewicz K, Janas A, Chorianopoulos A,  Zurakowski A, Buszman P, Milewski K. Long term outcome after revascularization of long coronary artery lesions with very long or overlapping stents. Insights from the propensity score matched registry. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY  Meeting Abstract: TCT-748  Volume: 70  Issue: 18  Pages: B317-B317  Supplement: S  Published: OCT 31 2017
     
  93. Buszman P, Nowakowski P, Milewski K, Orlik B, Zurakowski A, Ludyga T, Debinski M, Kachel M, Turek A, Granada J, Kiesz RS, Buszman P. Prospective, controlled, clinical randomized trial evaluating novel, microcrystalline and biodegradable polymer paclitaxel coated balloon for the treatment of femoro-popliteal disease (The BIOPAC trial) - one year outcome.  JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY  Meeting Abstract: TCT-563  Volume: 70  Issue: 18  Pages: B233-B233 
  94. Buszman P, Orlik B, Milewski K, Kachel M, Roleder T, Wojakowski W, Michalak M, Janas A, Polczyk F, Kolodgie F, Virmani R, Buszman P. Local intravascular delivery of low-density-lipoprotein cholesterol causes increased neointimal thickening in the healthy porcine coronary model. Insights into development of model of atherosclerosis. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY  Meeting Abstract: TCT-211  Volume: 70  Issue: 18  Pages: B89-B89  Supplement: S  Published: OCT 31 2017